| __timestamp | Genmab A/S | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 79529000 | 406114000 |
| Thursday, January 1, 2015 | 91224000 | 449119000 |
| Friday, January 1, 2016 | 102413000 | 502892000 |
| Sunday, January 1, 2017 | 146987000 | 544156000 |
| Monday, January 1, 2018 | 213695000 | 683530000 |
| Tuesday, January 1, 2019 | 342000000 | 736942000 |
| Wednesday, January 1, 2020 | 661000000 | 854233000 |
| Friday, January 1, 2021 | 1283000000 | 1451683000 |
| Saturday, January 1, 2022 | 2676000000 | 1416967000 |
| Sunday, January 1, 2023 | 3297000000 | 1343105000 |
| Monday, January 1, 2024 | 3790000000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, Genmab A/S and Jazz Pharmaceuticals plc have shown contrasting trends in their SG&A management. From 2014 to 2023, Genmab A/S's SG&A expenses surged by over 4,000%, peaking at approximately $3.3 billion in 2023. In contrast, Jazz Pharmaceuticals plc maintained a more stable trajectory, with a modest increase of around 230% over the same period, reaching about $1.34 billion in 2023.
This stark difference highlights Genmab's aggressive expansion strategy, possibly investing heavily in marketing and administrative capabilities. Meanwhile, Jazz Pharmaceuticals appears to have adopted a more conservative approach, focusing on steady growth. Understanding these strategies provides valuable insights into how these companies navigate the complex pharmaceutical landscape.
Zoetis Inc. and Genmab A/S: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of United Therapeutics Corporation and Genmab A/S
Genmab A/S and Incyte Corporation: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Genmab A/S and Axsome Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Genmab A/S and Ligand Pharmaceuticals Incorporated
Comparing SG&A Expenses: Bio-Techne Corporation vs Jazz Pharmaceuticals plc Trends and Insights
Cost Management Insights: SG&A Expenses for Jazz Pharmaceuticals plc and Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Bausch Health Companies Inc. Trends and Insights
Jazz Pharmaceuticals plc and Ligand Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Amphastar Pharmaceuticals, Inc.
Jazz Pharmaceuticals plc vs Xencor, Inc.: SG&A Expense Trends
Jazz Pharmaceuticals plc vs MiMedx Group, Inc.: SG&A Expense Trends